• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
934725

治療疫苗的全球市場:至2025年的各類型，各產品，各技術，各輸送機構，各終端用戶，各地區的預測和機會

Global Therapeutic Vaccines Market By Type, By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

在治療疫苗中，有成癮疫苗，自體免疫疾病疫苗，神經疾病疫苗，癌症疫苗，感染疾病疫苗等。為了對應消費者的需求，大型製藥公司今後將在世界各地的市場投入120種新疫苗，在致命疾病和慢性疾病的盛行率相關意識高漲中，市場預計以自體免疫疾病疫苗為中心今後以2位數的年複合成長率成長。

本報告提供全球治療疫苗市場調查，新型冠狀病毒感染疾病(COVID-19)對市場產生的影響，各地區市場展望，市場力學與趨勢，競爭情形和主要企業的簡介等資訊，同時再加上策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 新型冠狀病毒感染疾病(COVID-19)對市場產生的影響

第4章 客戶的迴響

第5章 摘要整理

第6章 全球市場的展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(抗原疫苗，樹突狀細胞疫苗，DNA疫苗，癌細胞疫苗)
    • 各產品(成癮疫苗，自體免疫疾病疫苗，神經疾病疫苗，癌症疫苗，感染疾病疫苗，其他)
    • 各技術(自體疫苗，同種異體疫苗)
    • 通知機構(經鼻給藥，電穿孔)
    • 各終端用戶(私立醫院，公立醫院，專門診所)
    • 各企業(2019)
    • 各地區
  • 市場魅力指數

第7章 亞太地區市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各類型
    • 各技術
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第8章 歐洲市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各類型
    • 各技術
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章 北美市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各類型
    • 各技術
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各類型
    • 各技術
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東、非洲市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各類型
    • 各技術
    • 各終端用戶
    • 各國
  • 中東、非洲地區:各國分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第12章 市場力學

  • 促進促進因素
  • 課題
  • 波特的五力分析闡明的課題

第13章 市場趨勢與趨勢

第14章 競爭情形

  • 競爭情形的展望
  • 主要企業的簡介
    • Sanofi Pasteur SA de CV
    • Intellect Neurosciences Inc
    • Agenus Inc
    • Celtic Pharma Holdings Advisors LLC
    • Novartis AG
    • Bavarian Nordic A/S
    • Transgene SA
    • Argos Therapeutics Inc
    • Celldex Therapeutics Inc
    • CureVac GmbH

第15章 策略性建議

第16章 免責聲明

目錄
Product Code: 4606

Global therapeutic vaccines market is expected to grow at a double digit CAGR during the forecast period on account of increasing awareness in the population about prevalence of fatal and chronic diseases. Moreover, on account of increasing demand from consumers, 120 new vaccines are also anticipated to be introduced globally by different multinational companies, thereby driving the market. Since vaccines are prepared for a special type of disease, it can be said that this market is a demand-based market.

Global therapeutic vaccines market is segmented on the basis of type, product, technology, delivery mechanism, end user, company and region. Type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others. Auto immune disease vaccines held the largest market share in 2019 as auto immune diseases are responsible for majority of deaths all over the world.

In terms of regional analysis, Asia-Pacific is anticipated to grow at the highest rate until 2025 owing to increasing patient awareness and improving healthcare infrastructure. Moreover, favorable regulations and initiatives taken by the government in the economies present in the region are positively impacting the growth of the market.

Leading players in the global therapeutic vaccines market include Sanofi Pasteur SA de CV, Intellect Neurosciences Inc, Agenus Inc, Celtic Pharma Holdings Advisors LLC, Novartis AG, Bavarian Nordic A/S, Transgene SA, Argos Therapeutics Inc, Celldex Therapeutics Inc, CureVac GmbH, etc. The companies operating in the global therapeutic vaccines market are adoption inorganic and organic growth strategies to increase their share in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

XXXXXObjective of the StudyYYYYY:

  • To analyze and forecast the market size of global therapeutic vaccines market.
  • To classify and forecast global therapeutic vaccines market based on type, product, technology, delivery mechanism, end user, company and region.
  • To identify drivers and challenges for global therapeutic vaccines market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic vaccines market.
  • To conduct pricing analysis for global therapeutic vaccines market.
  • To identify and analyze the profile of leading players operating in global therapeutic vaccines market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic vaccines market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

XXXXXKey Target AudienceYYYYY:

  • Therapeutic vaccines manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic vaccine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

XXXXXReport ScopeYYYYY:

In this report, global therapeutic vaccines market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Antigen Vaccine

Dendritic Cell Vaccine

DNA Vaccines

Tumor Cell Vaccine

  • Market, By Product:

Addiction Vaccines

Auto Immune Disease Vaccines

Neurological Disease Vaccines

Cancer Vaccines

Infectious Disease Vaccine

Others

  • Market, By Technology:

Autologous Vaccines

Allogeneic Vaccines

  • Market, By Delivery Mechanism:

Nasal

Electroporation

  • Market, By End User:

Private Hospitals

Government Hospitals

Specialty Clinics

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

XXXXXCompetitive LandscapeYYYYY

Company Profiles: Detailed analysis of the major companies present in global therapeutic vaccines market.

XXXXXAvailable CustomizationsYYYYY:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID 19 on Global Therapeutic Vaccines Market

4. Voice of Customers

5. Executive Summary

6. Global Therapeutic Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell vaccine)
    • 6.2.2. By Product (Addiction Vaccines, Auto Immune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccine, Others)
    • 6.2.3. By Technology (Autologous Vaccines, Allogeneic Vaccines)
    • 6.2.4. By Delivery Mechanism (Nasal, Electroporation)
    • 6.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)
    • 6.2.6. By Company (2019)
    • 6.2.7. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Therapeutic Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Therapeutic Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. India Therapeutic Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. Japan Therapeutic Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. South Korea Therapeutic Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Singapore Therapeutic Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User
    • 7.3.6. Australia Therapeutic Vaccines Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product Type
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By End User

8. Europe Therapeutic Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Therapeutic Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Therapeutic Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Therapeutic Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Therapeutic Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Therapeutic Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. North America Therapeutic Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Therapeutic Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Therapeutic Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Therapeutic Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. South America Therapeutic Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Therapeutic Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Therapeutic Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Therapeutic Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User

11. Middle East and Africa Therapeutic Vaccines Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Technology
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Therapeutic Vaccines Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Therapeutic Vaccines Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Therapeutic Vaccines Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges
  • 12.3. Porter's Five forces challenge

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Sanofi Pasteur SA de CV
    • 14.2.2. Intellect Neurosciences Inc
    • 14.2.3. Agenus Inc
    • 14.2.4. Celtic Pharma Holdings Advisors LLC
    • 14.2.5. Novartis AG
    • 14.2.6. Bavarian Nordic A/S
    • 14.2.7. Transgene SA
    • 14.2.8. Argos Therapeutics Inc
    • 14.2.9. Celldex Therapeutics Inc
    • 14.2.10. CureVac GmbH

15. Strategic Recommendations

16. About Us & Disclaimer